FDA Inspection 1024608 — Sanford Reproductive Medicine

Sanford Reproductive Medicine — FEI 3005043101

The FDA completed an inspection of Sanford Reproductive Medicine on August 14, 2017 in Fargo, ND. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 14, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fargo, ND (United States)